Targeted Co-delivery of Tumor Antigen and α-Galactosylceramide to CD141+ Dendritic Cells Induces a Potent Tumor Antigen-Specific Human CD8+ T Cell Response in Human Immune System Mice. [PDF]
Huang J +11 more
europepmc +1 more source
α-galactosylceramide generates lung regulatory T cells through the activated natural killer T cells in mice. [PDF]
Chen Q +11 more
europepmc +1 more source
4"-O-Alkylated α-Galactosylceramide Analogues as iNKT-Cell Antigens: Synthetic, Biological, and Structural Studies. [PDF]
Janssens J +8 more
europepmc +1 more source
Efficient Divergent Synthesis of New Immunostimulant 4″-Modified α-Galactosylceramide Analogues. [PDF]
Janssens J +8 more
europepmc +1 more source
Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration. [PDF]
Guevara ML +3 more
europepmc +1 more source
α-Galactosylceramide and peptide-based nano-vaccine synergistically induced a strong tumor suppressive effect in melanoma. [PDF]
Sainz V +13 more
europepmc +1 more source
α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma. [PDF]
Chen Q +11 more
europepmc +1 more source
α-Galactosylceramide-activated murine NK1.1(+) invariant-NKT cells in the myometrium induce miscarriages in mice. [PDF]
Ichikawa T +4 more
europepmc +1 more source
Administration of α-Galactosylceramide Improves Adenine-Induced Renal Injury. [PDF]
Aguiar CF +11 more
europepmc +1 more source

